Financial Enhancement Group LLC Acquires Shares of 1,638 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Financial Enhancement Group LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 1,638 shares of the medical equipment provider's stock, valued at approximately $884,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Godsey & Gibb Inc. grew its stake in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth $33,000. Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth $38,000. DT Investment Partners LLC grew its stake in shares of Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider's stock worth $40,000 after purchasing an additional 36 shares during the period. Finally, Mark Sheptoff Financial Planning LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth $37,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 0.7 %

Shares of ISRG stock traded up $3.97 during trading hours on Thursday, hitting $584.08. 2,119,290 shares of the company were exchanged, compared to its average volume of 1,655,838. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $585.50. The firm has a fifty day moving average of $538.34 and a 200 day moving average of $497.08. The firm has a market cap of $208.04 billion, a PE ratio of 93.90, a PEG ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 270 shares of the firm's stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company's stock, valued at $2,788,899.12. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 48,190 shares of company stock worth $25,012,927. Company insiders own 0.80% of the company's stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of research reports. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an "overweight" rating in a research note on Wednesday, December 11th. Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and increased their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Piper Sandler reissued an "overweight" rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. Finally, Evercore ISI reissued a "cautious" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.